Navigation Links
Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
Date:10/6/2009

the Company's performance by excluding certain expenses that may not be indicative of core business results. Gen-Probe believes that both management and investors benefit from referring to non-GAAP financial measures in assessing Gen-Probe's performance and when planning, forecasting and analyzing future periods. Non-GAAP financial measures also facilitate management's internal comparisons to Gen-Probe's historical performance and our competitors' operating results. Gen-Probe's management believes that non-GAAP financial measures provide Gen-Probe investors meaningful supplemental information regarding the expected financial results of the acquisition.

Caution Regarding Forward-Looking Statements

Any statements in this news release relating to Gen-Probe's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning the closing of the transaction, the expected benefits of the proposed acquisition and expected financial results are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. Some of these risks, uncertainties and assumptions include but are not limited to: (i) the risks that the closing conditions of the acquisition may not be satisfied, that closing will not occur, or that the closing conditions may take longer to satisfy than anticipated, (ii) the risk that Gen-Probe will not successfully integrate Prodesse or achieve expected strategic or financial benefits, (iii) facts relating to Prodesse that m
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
2. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
5. Carl Hull Named President and Chief Operating Officer of Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
7. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
8. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
9. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
10. Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
11. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2010)... - YM BioSciences Inc. (NYSE YMI, TSX:YM), today announced that it has closed its ... $1.20 for gross proceeds of approximately US $17.5 million . Each unit ... may be exercised to purchase one common share at US$1.60 until March ... ... ...
(Date:3/10/2010)... , ... ... ... , ... ...
(Date:3/10/2010)... , , ... ... ... , ... ...
(Date:3/10/2010)... Healthcare Data Solutions (HDS) has announced the addition of an ... responsible for optimizing sales and marketing potential by using analytics to ... be headed by Sahar Rashidi Meyer, Manager of Analytics based out ... ... -- Healthcare Data Solutions (HDS) has announced the addition ...
Breaking Biology Technology:YM BioSciences closes US$17.5 million financing 2YM BioSciences closes US$17.5 million financing 3YM BioSciences closes US$17.5 million financing 4Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 3BR Ventures Invests in Semprae Laboratories 2BR Ventures Invests in Semprae Laboratories 3BR Ventures Invests in Semprae Laboratories 4Healthcare Data Solutions Announces New AnalyticPRO division. 2Healthcare Data Solutions Announces New AnalyticPRO division. 3
... Call Today at 8:30 a.m. EST, SOUTH SAN FRANCISCO, ... today reported financial results for,the three and nine months ended ... Rigel reported a net loss of $37.7,million, or $1.03 per ... per share, in the third quarter of 2007. Weighted average ...
... 31 Memory,Pharmaceuticals Corp. (Nasdaq: MEMY ) ... granted the Company,s request for an,extension until December ... Market,minimum market capitalization requirement of $35 million or ... in order to remain,listed. There can be no ...
... Device Expands Less Invasive Surgical Options for Patients with Aortic ... ... 31 Arizona Heart Institute announced,today that its Division of Vascular ... newly FDA-approved, minimally invasive device,for the treatment of abdominal aortic aneurysms ...
Other Biology Technology:Rigel Announces Third Quarter 2008 Financial Results and Clinical Update 2Rigel Announces Third Quarter 2008 Financial Results and Clinical Update 3Rigel Announces Third Quarter 2008 Financial Results and Clinical Update 4Rigel Announces Third Quarter 2008 Financial Results and Clinical Update 5Rigel Announces Third Quarter 2008 Financial Results and Clinical Update 6Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 2Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval 2Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval 3
(Date:3/9/2010)... a species of tree defends itself from herbivore ... The study, published today in New Phytologist ... adsorbs chemical compounds from neighbouring marsh tea plants, ... by neighbour strategy., , The team from Finland, ... of Eastern Finland, were conducting studies into emissions ...
(Date:3/9/2010)... MARCH 8, 2010--Polycyclic aromatic hydrocarbons (PAHs) are components of ... are also produced as by-products of the combustion of ... cancer and other health effects. Because they are produced ... high enough to be a concern in all urban ... of PAHs in the environment, it is not clear ...
(Date:3/9/2010)... Western medicine for anticancer powers that folk cultures have ... Dang, M.D., Ph.D., and colleagues in Japan have documented ... lab-grown tumors, including cancers of the cervix, breast, liver, ... from dried papaya leaves, and the anticancer effects were ... , In a paper published in the Feb. 17 ...
Breaking Biology News(10 mins):Plants discover the benefits of good neighbors in strategy against herbivores 2Sources of pollution in waterways 2Papaya extract thwarts growth of cancer cells in lab tests 2The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 1The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 2The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 3The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 4The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 5Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 1Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 3UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 1UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 2UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 3
... the Biometrics Operations and Support Services Unrestricted (BOSS-U) ... Science Applications International Corporation (NYSE: SAI ... contract by the Army,s Biometrics Task Force (BTF) ... the Biometrics Operations and Support Services Unrestricted (BOSS-U) ...
... daily nutritional supplement for three months had a lower rate of ... who did not receive the supplementation, according to a study in ... as a certain deviation that a child,s weight is from the ... a reference group) is characterized by the loss of weight and ...
... and sheer numbers, the microbes occupying the human gut ... Numbering in the tens of trillions and representing many ... called, helps the body perform a variety of regulatory ... How this microbial mlange may be linked to body ...
Other Biology News:U.S. Army Biometrics Task Force Awards Contract to SAIC 2Nutritional supplementation program helps prevent weight loss among children in African country 2Nutritional supplementation program helps prevent weight loss among children in African country 3Our microbes, ourselves 2Our microbes, ourselves 3Our microbes, ourselves 4
Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Thermo Forma provides an array of accessory Racks for the Cryo/CryoPlus 16" Diameter storage system. To maximise inventory capacity a Jumbo Arrowhead configuration is recommended. You may choose betw...
Immulon 1 B 1x12 Strip, flat bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
Biology Products: